+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Growth Opportunities in Digital, Microbiome-based, and Preventive Healthcare Technologies 2020

  • ID: 5150036
  • Report
  • August 2020
  • Region: Global
  • 66 Pages
  • Frost & Sullivan

Enquire about COVID-19 updates for this product.

Enquire Now
Insights Across Latest Advancements for Chronic Pain Management and COVID-19 Testing

FEATURED COMPANIES

  • Adagio Therapeutics
  • Blue Water Vaccines Inc.
  • F2G
  • Iqur Limited
  • Osivax
  • Sangamo Therapeutics Inc.
  • MORE

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent innovations in digital health, microbiome, and flu vaccines technologies. The TOE also provides insights across latest advancements for chronic pain management and COVID-19 testing.

The TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Adagio Therapeutics
  • Blue Water Vaccines Inc.
  • F2G
  • Iqur Limited
  • Osivax
  • Sangamo Therapeutics Inc.
  • MORE
  1. Growth Opportunities in Digital, Microbiome-Based, and Preventive Healthcare Technologies
  2. Innovations in Life Sciences, Health & Wellness
  3. Molomics, Barcelona, Spain - Growth Opportunities
  4. Repurpose.AI, US - Growth Opportunities
  5. Cyclica Rx, Canada - Growth Opportunities
  6. Biondvax, Israel - Growth Opportunities
  7. Flugen Inc. US - Growth Opportunities
  8. Imutex, UK - Growth Opportunities
  9. Blue Water Vaccines Inc. US - Growth Opportunities
  10. Seqirus Ltd. UK - Growth Opportunities
  11. Iqur Limited, UK - Growth Opportunities
  12. Osivax, France - Growth Opportunities
  13. Vivaldi Biosciences, US - Growth Opportunities
  14. Emergex Vaccines Holding Ltd. UK - Growth Opportunities
  15. Adagio Therapeutics, US - Growth Opportunities
  16. Iggenix, US - Growth Opportunities
  17. Duke-Nus Medical School, Singapore - Growth Opportunities
  18. Biorelate, UK - Growth Opportunities
  19. Pieriandx, US - Growth Opportunities
  20. Blackthorn Therapeutics, US - Growth Opportunities
  21. Sangamo Therapeutics Inc. US - Growth Opportunities
  22. Seres Therapeutics Inc. US - Growth Opportunities
  23. American Gene Technologies Inc. US - Growth Opportunities
  24. F2G, UK - Growth Opportunities
  25. Kineta, US - Growth Opportunities
  26. DNA Script, France - Growth Opportunities
  27. Reapplix A/S, Denmark - Growth Opportunities
  28. Novozymes, Denmark - Growth Opportunities
  29. Key Contacts
Note: Product cover images may vary from those shown
  • Adagio Therapeutics
  • American Gene Technologies Inc.
  • Biondvax
  • Biorelate
  • Blackthorn Therapeutics
  • Blue Water Vaccines Inc.
  • Cyclica Rx
  • DNA Script
  • Duke-Nus Medical School
  • Emergex Vaccines Holding Ltd.
  • F2G
  • Flugen Inc. US
  • Iggenix
  • Imutex
  • Iqur Limited
  • Kineta
  • Molomics
  • Novozymes
  • Osivax
  • Pieriandx
  • Reapplix A/S
  • Repurpose.AI
  • Sangamo Therapeutics Inc.
  • Seqirus Ltd.
  • Seres Therapeutics Inc.
  • Vivaldi Biosciences
Note: Product cover images may vary from those shown
Adroll
adroll